Login / Signup

Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al.

Lea C BerkhoutMerel J l'AmiGerrit Jan WolbinkTheo Rispens
Published in: Annals of the rheumatic diseases (2019)
Keyphrases
  • ulcerative colitis
  • disease activity
  • rheumatoid arthritis
  • systemic lupus erythematosus